Tilmacoxib
Appearance
![]() | |
![]() | |
Pharmacokineticdata | |
---|---|
Bioavailability | solution (64–88%) compared with capsule (22–40%). |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C16H19FN2O3S |
Molar mass | 338.40g·mol−1 |
3D model (JSmol) | |
| |
|
TilmacoxiborJTE-522is aCOX-2 inhibitorand is an effective chemopreventive agent against rat experimental liver fibrosis.[1]
See also
[edit]References
[edit]- ^Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, Sugita Y, et al. (August 2003)."JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1".Gastroenterology.125(2): 556–71.doi:10.1016/s0016-5085(03)00904-1.PMID12891558.